Home » Topics » Regulatory » Patents

Patents
RSS

Nikken Chemicals presents new antiasthmatic agents

June 3, 1998

Compounds for schizophrenia without EPS developed at AHP

June 3, 1998

Antimicrotubule cryptophycins developed by Lilly, U.S. university researchers

June 3, 1998

Procter & Gamble prepares inhibitors of mammalian metalloproteases

June 3, 1998

New Lilly compounds for postmenopausal syndrome

June 3, 1998

Inhibitors of cysteine protease from SKB for bone and cartilage disorders

June 3, 1998

Potent new cholesterol biosynthesis inhibitors reported by Novartis

June 2, 1998

New lipoxygenase inhibitors for asthma and other inflammatory conditions

June 2, 1998

MMP/TNF-alpha convertase inhibitors disclosed by Agouron

June 1, 1998

Muscarinic receptor ligands from AHP with potential in treating cognition disorders

June 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...